Enhancing the detection of MRD in patients with B-cell malignancies

• Research type

  Research Study

• Full title

  To develop the CD160 flow cytometric assay to enhance the detection of disease & Minimal Residual Disease (MRD) in patients with chronic B-cell malignancies including monoclonal B-cell lymphocytosis.

• IRAS ID

  105378

• Contact name

  Samir G. Agrawal

• Contact email

  s.g.agrawal@qmul.ac.uk

• Sponsor organisation

  Joint Research Management Office (JRMO)

• REC name

  London - Westminster Research Ethics Committee

• REC reference

  13/LO/0284

• Date of REC Opinion

  4 Mar 2013

• REC opinion

  Favourable Opinion